5-HT1A receptor binding changes in patients with major depressive disorder before and after antidepressant treatment: A pilot [18F]MPPF positron emission tomography study

Psychiatry Research - Neuroimaging

Volumn 203, Issue 1, 2012, Pages 103-104

  Lothe, Amélie ^a,b,c,d   Saoud, Mohamed ^a,b,f   Bouvard, Sandrine ^a,b,c,d,e   Redouté, JérÔme ^e   Lerond, JérÔme ^a,b,f   Ryvlin, Philippe ^a,b,c,d,g  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c Hospices Civils de Lyon   (France)

^d LYON NEUROSCIENCE RESEARCH CENTER   (France)

^e CERMEP IMAGERIE DU VIVANT   (France)

^f CENTRE HOSPITALIER LE VINATIER   (France)

^g HOSPICES CIVILS DE LYON   (France)

Author keywords

Depression; Limbic regions; Selective serotonin reuptake inhibitor (SSRI)

Indexed keywords

MPPF F 18; PAROXETINE; RADIOPHARMACEUTICAL AGENT; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING;

ADULT; DEPRESSIVE DISORDER, MAJOR; FEMALE; FLUORINE RADIOISOTOPES; FRONTAL LOBE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN 5-HT1 RECEPTOR ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 84866295185     PISSN: 09254927     EISSN: 18727506     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2011.09.001     Document Type: Article

References (13)

1. 18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain. Neuropharmacology 2007, 52:695-707.
2. Buchsbaum M.S., Wu J., Siegel B.V., Hackett E., Trenary M., Abel L., Reynolds C. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biological Psychiatry 1997, 41(1):15-22.
3. 18F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. Journal of Cerebral Blood Flow and Metabolism 2002, 22:753-765.
4. Drevets W.C. Orbitofrontal cortex function and structure in depression. Annals of the New York Academy of Science 2007, 1121:499-527.
5. Drevets W.C., Savitz J., Trimble M. The subgenual anterior cingulate cortex in mood disorders. CNS Spectrums 2008, 13:663-681.
6. Gousias I.S., Rueckert D., Heckemann R.A., Dyet L.E., Boardman J.P., Edwards A.D., Hammers A. Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest. NeuroImage 2008, 40:672-684.
7. Gunn R.N., Sargent P.A., Bench C.J., Rabiner E.A., Osman S., Pike V.W., Hume S.P., Grasby P.M., Lammertsma A.A. Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET. NeuroImage 1998, 8:426-440.
8. Hammers A., Allom R., Koepp M.J., Free S.L., Myers R., Lemieux L., Mitchell T.N., Brooks D.J., Duncan J.S. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Human Brain Mapping 2003, 19:224-247.
9. Karlsson H., Hirvonen J., Kajander J., Markkula J., Rasi-Hakala H., Salminen J.K., Någren K., Aalto S., Hietala J. Research letter: psychotherapy increases brain serotonin 5-HT1A receptors in patients with major depressive disorder. Psychological Medicine 2010, 40(3):523-528.
10. 18F]MPPF PET study. Brain 2008, 131:2765-2782.
11. 11C]WAY-100635. Synapse 2007, 61:523-530.
12. 11C]WAY-100635: effects of depression and antidepressant treatment. Archives of General Psychiatry 2000, 57:174-180.
13. Savitz J., Lucki I., Drevets W.C. 5-HT(1A) receptor function in major depressive disorder. Progress in Neurobiology 2009, 88(1):17-31.